Pfizer prevails in Rost whistleblower suit

After several years of legal sparring, a federal judge has dismissed the whistleblower lawsuit that controversial Pfizer exec Peter Rost filed against the company, alleging that it had marketed Genotropin, a human growth hormone, for unapproved uses. Report

Suggested Articles

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

Data on Roche's Polivy aren't yet enough to win support from England's cost watchdogs, who rejected the medicine based on long-term…